Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study

By afschroeder • July 6, 2025

Aggarwal R, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Clodi E, Levine T, Charles-Schoeman C; ProDERM investigators. Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study. Rheumatol Ther. 2025 Jul 5. doi: 10.1007/s40744-025-00775-5. Epub ahead of print. PMID: 40616720.

Tags: Arthralgia, Arthritis, Constitutional, Dermatomyositis, gastrointestinal, Immunoglobulins, Intravenous, Octagam, Publications, pulmonary, Rheumatology, Skeletal

Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis

Kishan AU, Sun Y, Parker CC, Sargos P, Sydes MR, Chabaud S, Brihoum M, Kalbasi TR, Steinberg ML, Valle LF, Taparra K, Shoag JE, Garcia[...]

Rebuilding the foundation: recommendations from the Summit to Revitalize Primary Care (Rev PC)

Summit to Revitalize Primary Care Writing Committee*; Jerant A, Kravitz RL, Fenton JJ, Lyles CR, Grumbach K, Henderson MC, Ritley D, Brandt M, Cohen D,[...]

Hepatocyte growth factor may contribute to male protection against pulmonary arterial hypertension

Medzikovic L, Ruffenach G, Dehghanitafti A, Wong B, Ryder A, Hatamnejad MR, Sun W, Esdin L, Eghbali J, Brownstein A, Razee A, Umar S, Hong[...]